Treating prediabetes in the obese: are GLP-1 analogues the answer?
- PMID: 28237265
- DOI: 10.1016/S0140-6736(17)30315-X
Treating prediabetes in the obese: are GLP-1 analogues the answer?
Comment on
-
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Lancet. 2017. PMID: 28237263 Clinical Trial.
Similar articles
-
GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study.Diabetes. 2015 Jul;64(7):2513-25. doi: 10.2337/db14-1751. Epub 2015 Feb 12. Diabetes. 2015. PMID: 25677912
-
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.Expert Opin Pharmacother. 2014 Dec;15(17):2487-500. doi: 10.1517/14656566.2014.965678. Epub 2014 Sep 26. Expert Opin Pharmacother. 2014. PMID: 25260877 Review.
-
Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513-2525.Diabetes. 2015 Sep;64(9):e28-9; discussion e30-1. doi: 10.2337/db15-0614. Diabetes. 2015. PMID: 26294437 No abstract available.
-
Is there a place for incretin therapies in obesity and prediabetes?Trends Endocrinol Metab. 2013 Mar;24(3):145-52. doi: 10.1016/j.tem.2013.01.004. Epub 2013 Feb 14. Trends Endocrinol Metab. 2013. PMID: 23415157 Review.
-
Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.J Clin Endocrinol Metab. 2002 Aug;87(8):3768-73. doi: 10.1210/jcem.87.8.8743. J Clin Endocrinol Metab. 2002. PMID: 12161508 Clinical Trial.
Cited by
-
Family Involvement to Stop the Conversion of Prediabetes to Diabetes.Korean J Fam Med. 2023 Nov;44(6):303-310. doi: 10.4082/kjfm.23.0019. Epub 2023 Aug 14. Korean J Fam Med. 2023. PMID: 37582666 Free PMC article.
-
Prevention of Diabetes Mellitus in Patients With Prediabetes.Am J Cardiol. 2019 Feb 1;123(3):507-512. doi: 10.1016/j.amjcard.2018.10.032. Epub 2018 Nov 6. Am J Cardiol. 2019. PMID: 30528418 Free PMC article. Review.
-
Glycemic and metabolic sub-classification of prediabetes and risk factors for cardiovascular disease in the D2d cohort.Am J Prev Cardiol. 2023 Jul 27;15:100525. doi: 10.1016/j.ajpc.2023.100525. eCollection 2023 Sep. Am J Prev Cardiol. 2023. PMID: 37650052 Free PMC article.
-
The Longitudinal Epidemiologic Assessment of Diabetes Risk (LEADR): Unique 1.4 M patient Electronic Health Record cohort.Healthc (Amst). 2020 Dec;8(4):100458. doi: 10.1016/j.hjdsi.2020.100458. Epub 2020 Oct 1. Healthc (Amst). 2020. PMID: 33011645 Free PMC article.
-
A Systematic Approach to Treating Early Metabolic Disease and Prediabetes.Diabetes Ther. 2023 Oct;14(10):1595-1607. doi: 10.1007/s13300-023-01455-9. Epub 2023 Aug 5. Diabetes Ther. 2023. PMID: 37543535 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical